Given the mechanistic parallels between PD-L1-negative NSCLC and pMMR CRC-both characterized by T-cell exclusion and ICI resistance—we hypothesized that BRICS could address the critical unmet need in refractory pMMR/MSS metastatic CRC. Here, CD274 is linked to non-small cell lung carcinoma.